Ochsner Health COVID-19 SharePoint Site "Safety On Site" Click here to enter an S.O.S.
Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Search results for:

vutrisiran

vutrisiran
Drug Name Form Strength Infusion Center Available Restricted Non-formulary Ambulatory Available Interchange REMS
Amvuttra SOLUTION, SUBCUTANEOUS 25 mg/0.5 mL      


Additional Information and Links

Formulary restrictions:

  • Indication: polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR)
  • Service line: Cardiology, Neurology
  • Formulary location: Outpatient Infusion, Ambulatory
  • Service location: Heart Failure Clinic/Infusion, Ambulatory/ID Infusion
  • Patient population: adults
  • Prior authorization required: Yes
  • Restriction/criteria of use (all will apply unless specified):
    • Confirmed diagnosis of hATTR-PN with documentation of a mutation in the TTR gene
    • Currently experiencing signs and symptoms of polyneuropathy, including peripheral or autonomic
    • Complete electromyography (EMG) of bilateral lower extremities for evidence of polyneuropathy
    • No concomitant use of a TTR-lowering agent (e.g., inotersen (Tegsedi) and patisiran (Onpattro))
    • No prior or planned liver transplantation
    • No known other forms of neuropathy

Last updated: Sep. 14, 2023
  • Ambulatory: Ambulatory/ID Infusion


This site is intended for the staff of Ochsner Health. While others may view accessible pages, Ochsner Health makes no warranty, express or implied, as to the use of this information outside of Ochsner Health.